George Golumbeski Sage Therapeutics, Inc. (SAGE) insider trading activity

George Golumbeski is of Sage Therapeutics, Inc.. Currently has a direct ownership of 0 shares of SAGE, which is worth approximately $0. The most recent transaction as insider was on Jul 31, 2025, when has been sold 8,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

George Golumbeski Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jul 31 2025	SELL Disposition due to a tender of shares in a change of control transaction	-	8,000 Reduced 100.0%	0 Common Stock
May 05 2022	BUY Open market or private purchase	$251,600 $31.45 p/Share	8,000 Added 50.0%	8,000 Common Stock

Also insider at

STTK

Shattuck Labs, Inc. Healthcare

MURA

Mural Oncology plc